Key result
TTK-Chitra AVR linked to ~16% lower LV mass at one year.
Why the study?
Although the TTK Chitra valve is extensively used in India, few studies evaluate its performance in the Indian population.
Does the TTK-Chitra valve improve functional class and hemodynamics in patients undergoing aortic valve replacement for aortic stenosis?
Observational (n=75)
No
Does the TTK-Chitra valve improve functional class and hemodynamics in patients undergoing aortic valve replacement for aortic stenosis?
The TTK-Chitra prosthetic heart valve provides significant functional improvement in Indian patients undergoing aortic valve replacement for aortic stenosis.
Answers are grounded in this paper and cite their sources.
LV mass reduction with TTK-Chitra AVR may indicate hemodynamic benefit; leaves open comparative efficacy versus other valves in randomized trials.
TTK Chitra valve is one of the most extensively used prosthetic heart valves in our country, yet not many studies of this valve are available pertaining to the Indian population. TTK Chitra valve is commonly used in our Institute and we decided to do a prospective study on short and mid-term results of TTK Chitra valve in aortic position in patients with aortic stenosis. Patients were taken up for aortic valve replacement after detailed informed consent including consent for lifelong anticoagulation and it’s management. Aortic valve replacement was done under general anaesthesia, on cardiopulmonary bypass as per existing standard operating practice detailed later. The intra-operative and postoperative data were collected in the study Performa. Echocardiography was performed postoperatively, on the day of surgery, prior to shifting to ward, prior to discharge, once at three months and once at one year follow up and then yearly thereafter. Sixty seven of 75 patients [89.3%] were in NYHA II, 7 patients [9.3%] and 1 patient [1.3%] in class III and IV respectively. There was significant improvement in functional class post operatively following the aortic valve replacement. 70 patients [93.3%] patients were in NYHA class I following surgery.
No takes yet. Share an insight, caveat, or question.
Rao et al. (2020) conducted an observational in Aortic stenosis (n=75). TTK-Chitra valve vs. Baseline was evaluated on Left ventricular mass (g) at 1 year (p=<0.001). Aortic valve replacement with the TTK-Chitra valve reduced mean left ventricular mass from 197.9 g at baseline to 166.46 g at 1 year.
Synapse has enriched 10 related papers. Consider them for comparative context: